Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Nonalcoholic Steatohepatitis
NCT00590161Phase 2Completed
- Sponsor
- Case Western Reserve University
- Start
- Dec 2006
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Nonalcoholic steatohepatitis (NASH) comparing Pentoxifylline with Placebo (2 arms). Primary endpoint: Histological Improvement of at Least 2 Points in NAFLD Activity Score (NAS) at 1 year. Started Dec 2006; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00590161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590161.